Cullinan Therapeutics Inc (CGEM)
R&D Expenses
$44.44M
Quarterly · Period ending: · USD
CGEM R&D Expenses
Latest reported$44.44Mperiod ending
Latest reported$44.44Mperiod ending
CGEM Quarterly R&D Expenses ($3.86M → $44.44M)
Quarterly R&D Expenses
High-resolution chart · PNG
CGEM r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 44,437,000 | |
| 42,123,000 | |
| 42,945,000 | |
| 41,968,000 | |
| 61,030,000 | |
| 41,459,000 | |
| 40,492,000 | |
| 35,506,000 | |
| 36,259,000 | |
| 30,646,000 | |
| 34,848,000 | |
| 33,821,000 | |
| 27,391,000 | |
| 52,096,000 | |
| 21,321,000 | |
| 19,680,000 | |
| 26,411,000 | |
| 24,536,000 | |
| 20,878,000 | |
| 12,680,000 | |
| 11,778,000 | |
| 12,415,000 | |
| 16,629,000 | |
| 9,913,000 | |
| 12,496,000 | |
| 4,173,000 | |
| 3,802,000 | |
| 5,276,000 | |
| 3,855,000 | |
| 3,855,000 |